157 related articles for article (PubMed ID: 14632662)
1. Toll-like receptor-9 induced by physical trauma mediates release of cytokines following exposure to CpG motif in mouse skin.
Liu L; Zhou X; Shi J; Xie X; Yuan Z
Immunology; 2003 Nov; 110(3):341-7. PubMed ID: 14632662
[TBL] [Abstract][Full Text] [Related]
2. Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells.
An H; Yu Y; Zhang M; Xu H; Qi R; Yan X; Liu S; Wang W; Guo Z; Guo J; Qin Z; Cao X
Immunology; 2002 May; 106(1):38-45. PubMed ID: 11972630
[TBL] [Abstract][Full Text] [Related]
3. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
Hong Z; Jiang Z; Liangxi W; Guofu D; Ping L; Yongling L; Wendong P; Minghai W
Int Immunopharmacol; 2004 Feb; 4(2):223-34. PubMed ID: 14996414
[TBL] [Abstract][Full Text] [Related]
4. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptors 2 and 4, and acute phase cytokine gene expression in dexamethasone and growth hormone treated dairy calves.
Eicher SD; McMunn KA; Hammon HM; Donkin SS
Vet Immunol Immunopathol; 2004 Apr; 98(3-4):115-25. PubMed ID: 15010221
[TBL] [Abstract][Full Text] [Related]
6. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
[TBL] [Abstract][Full Text] [Related]
7. Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA.
Suzuki K; Suda T; Naito T; Ide K; Chida K; Nakamura H
Am J Respir Crit Care Med; 2005 Apr; 171(7):707-13. PubMed ID: 15640365
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.
Tabeta K; Georgel P; Janssen E; Du X; Hoebe K; Crozat K; Mudd S; Shamel L; Sovath S; Goode J; Alexopoulou L; Flavell RA; Beutler B
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3516-21. PubMed ID: 14993594
[TBL] [Abstract][Full Text] [Related]
9. TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells.
Matsushima H; Yamada N; Matsue H; Shimada S
J Immunol; 2004 Jul; 173(1):531-41. PubMed ID: 15210814
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells.
Schaefer TM; Desouza K; Fahey JV; Beagley KW; Wira CR
Immunology; 2004 Jul; 112(3):428-36. PubMed ID: 15196211
[TBL] [Abstract][Full Text] [Related]
11. Murine thymic plasmacytoid dendritic cells.
Okada T; Lian ZX; Naiki M; Ansari AA; Ikehara S; Gershwin ME
Eur J Immunol; 2003 Apr; 33(4):1012-9. PubMed ID: 12672067
[TBL] [Abstract][Full Text] [Related]
12. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
[TBL] [Abstract][Full Text] [Related]
13. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells.
Bourke E; Bosisio D; Golay J; Polentarutti N; Mantovani A
Blood; 2003 Aug; 102(3):956-63. PubMed ID: 12689944
[TBL] [Abstract][Full Text] [Related]
14. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens.
Kadowaki N; Ho S; Antonenko S; Malefyt RW; Kastelein RA; Bazan F; Liu YJ
J Exp Med; 2001 Sep; 194(6):863-9. PubMed ID: 11561001
[TBL] [Abstract][Full Text] [Related]
15. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of Toll-like receptor mRNAs in experimental murine central nervous system infections.
Böttcher T; von Mering M; Ebert S; Meyding-Lamadé U; Kuhnt U; Gerber J; Nau R
Neurosci Lett; 2003 Jun; 344(1):17-20. PubMed ID: 12781911
[TBL] [Abstract][Full Text] [Related]
17. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M
Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes.
Matsumura T; Ito A; Takii T; Hayashi H; Onozaki K
J Interferon Cytokine Res; 2000 Oct; 20(10):915-21. PubMed ID: 11054280
[TBL] [Abstract][Full Text] [Related]
19. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
Zhang Z; Guo K; Schluesener HJ
J Neuroimmunol; 2005 Apr; 161(1-2):68-77. PubMed ID: 15748945
[TBL] [Abstract][Full Text] [Related]
20. TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells.
Olbert PJ; Kesch C; Henrici M; Subtil FS; Honacker A; Hegele A; Hofmann R; Hänze J
Urol Oncol; 2015 Mar; 33(3):110.e19-27. PubMed ID: 25499923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
